Regulation of serum phosphate

Journal of Physiology

Volumn 592, Issue 18, 2014, Pages 3985-3995

  Lederer, Eleanor ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; PARATHYROID HORMONE; PHOSPHATE; SODIUM PHOSPHATE COTRANSPORTER; VITAMIN D; HORMONE;

AGE; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; DIET; DOPAMINE METABOLISM; FAMILIAL HYPOCALCIURIC HYPOCALCAEMIA; FAMILIAL HYPOPHOSPHATEMIC RICKETS; GENDER; HEREDITY; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOPARATHYROIDISM; KIDNEY FUNCTION; ONCOGENIC OSTEOMALACIA; PARATHYROID HORMONE RELEASE; PHOSPHATE BLOOD LEVEL; PHOSPHATE EXCRETION; PHOSPHATE METABOLISM; PRIMARY HYPERPARATHYROIDISM; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOHYPOPARATHYROIDISM; REVIEW; RISK FACTOR; SARCOIDOSIS; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN D DEFICIENCY; ANIMAL; BLOOD; HOMEOSTASIS; HUMAN; METABOLISM;

ANIMALS; HOMEOSTASIS; HORMONES; HUMANS; PHOSPHATES;

EID: 84907875383     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.273979     Document Type: Review

References (73)

1. Abraham MI, McAteer JA & Kempson SA (1990). Insulin stimulates phosphate transport in opossum kidney epithelial cells. Am J Physiol Renal Physiol 258, F114- F121.
2. ADHR Consortium (2000). Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26, 345-348.
3. Alcalde AI, Sarasa M, Raldua D, Aramayona J, Morales R, Biber J, Murer H, Levi M & Sorribas V (1999). Role of thyroid hormone in regulation of renal phosphate transport in young and aged rats. Endocrinology140, 1544- 1551.
4. Ba J & Friedman PA (2004). Calcium-sensing receptor regulation of renal mineral ion transport. Cell Calcium 35, 229-237.
5. Bansal N, Hsu C-y,Whooley M, Berg AH & Ix JH (2012). Relationship of urine dopamine with phosphorus homeostasis in humans: the Heart and Soul Study. Am J Nephrol 35, 483-490.
6. Beck L, Karaplis AC, Amizuka N, Hewson AS, Ozawa H & Tenenhouse HS (1998). Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci U S A 95, 5372-5377.
7. Beers KW & Dousa TP (1993). Thyroid hormone stimulates the Na+-PO4 symporter but not the Na+-SO4 symporter in renal brush border. Am J Physiol Renal Physiol 265, F323-F326.
8. Bhadada SK, Palnitkar SJ, Qiu S, Parikh N, Talpos GB & Rao SD (2013). Deliberate total parathyroidectomy: a potentially novel therapy for tumor-induced hypophosphatemic osteomalacia. J Clin Endocrinol Metab 98, 4273-4278.
9. Bielesz B, Bacic D, Honegger K, Biber J, Murer H &Wagner CA (2006). Unchanged expression of the sodium-dependent phosphate cotransporter NaPi-IIa despite diurnal changes in renal phosphate excretion. Pflugers Arch 452, 683-689.
10. Bikle D, Adams JS & Christakos S (2013). Vitamin D: production, metabolism, mechanism of action and clinical requirements. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 8th edn., ed. Rosen CJ, pp. 235-248. American Society for Bone and Mineral Research, Washington, DC, USA.
11. Blaine J,Weinman EJ & Cunningham R (2011). The regulation of renal phosphate transport. Adv Chronic Kidney Dis 18, 77-84.
12. Bricker N (1972). On the pathogenesis of the uremic state. An exposition of the 'trade off hypothesis'. N Engl J Med 286, 1093-1099.
13. Brown AJ, Zhang F & Ritter CS (2012). The vitamin D analog ED-71 is a potent regulator of intestinal phosphate absorption and NaPi-IIb. Endocrinology 153, 5150-5156.
14. Capasso G, Geibel PJ, Damiano S, Jaeger P, RichardsWG & Geibel JP (2013). The calcium sensing receptor modulates fluid reabsorption and acid secretion in the proximal tubule. Kidney Int 84, 277-284.
15. Capuano P, Radanovic T, Wagner CA, Bacic D, Kato S, Uchiyama Y, St-Arnoud R, Murer H & Biber J (2005). Intestinal and renal adaptation to a low-Pi diet of type II NaPi cotransporters in vitamin D receptor- and 1αOHase-deficient mice. Am J Physiol Cell Physiol 288, C429-C434.
16. Caverzasio J & Bonjour JP (1989). Insulin-like growth factor I stimulates Na-dependent Pi transport in cultured kidney cells. Am J Physiol Renal Physiol 257, F712-F717.
17. Caverzasio J, Montessuit C & Bonjour JP (1990). Stimulatory effect of insulin-like growth factor-1 on renal Pi transport and plasma 1,25-dihydroxyvitamin D3. Endocrinology 127, 453-459.
18. Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Rejnmark L, Brixen K & Mosekilde L (2008). Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism. Eur J Endocrinol 159, 719-727.
19. Cirillo M, Bilancio G & Marcarelli F (2010). Ageing and changes in phosphate transport: clinical implications. J Nephrol 23 (Suppl. 16), S152-S157.
20. Courbebaisse M, Leroy C, Bakouh N, Salaun C, Beck L, Grandchamp B, Planelles G, Hall RA, Friedlander G & Prie D (2012). A new human NHERF1 mutation decreases renal phosphate transporter NpT2a expression by a PTH-independent mechanism. PLoS One 7, e34764.
21. Ellam TJ & Chico TJ (2012). Phosphate: the new cholesterol? The role of the phosphate axis in nonuremic vascular disease. Atherosclerosis 220, 310-318.
22. Ellam T,Wilkie M, Chamberlain J, Crossman D, Eastman R, Francis S & Chico TJ (2011). Dietary phosphate modulates atherogenesis and insulin resistance in apolipoprotein E knockout mice - brief report. Arterioscler Thromb Vasc Biol 31, 1988-1990.
23. Felsenfeld AJ, Jara A, Avedian G & Kleeman CR (2000). Effects of fasting, feeding, and bisphosphonate administration on serum calcitriol levels in phosphate-deprived rats. Kidney Int 58, 1016-1022.
24. Gutierrez OM (2010). Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the 'trade-off' hypothesis. Clin J Am Soc Nephrol 5, 1710-1716.
25. Guttmann-Rubinstein L, Lichtstein D, Ilani A, Gal-Moscovici A, Scherzer P & Rubinger D (2010). Evidence of a parathyroid hormone-independent chronic effect of estrogen on renal phosphate handling and sodium-dependent phosphate cotransporter type IIa expression. Horm Metab Res 42, 230-236.
26. Hammerman MR, Rogers S, Hansen VA & Gavin JR 3rd (1984). Insulin stimulates Pi transport in brush border vesicles from proximal tubular segments. Am J Physiol Endocrinol Metab 247, E616-E624.
27. Hoppe A, Metler M, Berndt TJ, Knox FG & Angielski S (1982). Effect of respiratory alkalosis on renal phosphate excretion. Am J Physiol Renal Physiol 243, F471-F475.
28. Hough FS (1987). Alterations of bone and mineral metabolism in diabetes mellitus. Part II. Clinical studies in 206 pateints with Type I diabetes mellitus. S AfrMed J 72, 120-126.
29. Hu MC, Shi M, Zhang J, Pastor J, Nakatani T, Lanske B, Razzaque MS, Rosenblatt KP, Baum MG, Kuro-o M et al. (2010). Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 24, 3438-3450.
30. Ichikawa S, Austin AM, Gray AK & Econs MJ (2012). A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells. J Bone Miner Res 27, 453-460.
31. Ikawa T, Sandoval-Cooper MJ, Tenenhouse HS & Castellino FJ (2008). A missense mutation in the sodium phosphate co-transporter Slc34a1 impairs phosphate homeostasis. J Amer Soc Nephrol 19, 1753-1762.
32. Ito N, Findlay DM, Anderson PH, Bonewald LF & Atkins GJ (2013). Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D3 (1,25D) on osteocyte like cells. J Steroid Biochem Mol Biol 136, 183-186.
33. Karim Z, Gerard B, Bakouh N, Alili R, Leroy C, Beck L, Silve C, Planelles G, Urena-Torres P, Grandchamp B et al. (2008). NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med 359, 1128-1135.
34. Kawata T, Imanishi Y, Kobayashi K, Miki T, Arnold A, Inaba M & Nishizawa Y (2007). Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J Am Soc Nephrol 18, 2683-2688.
35. Keating FR Jr, Jones JD, Elveback LR & Randall RV (1969). The relation of age and sex to distribution of values in healthy adults of serum calcium, inorganic phosphorus, magnesium, alkaline phosphatase, total proteins, albumin and blood urea. J Lab ClinMed 73, 825-834.
36. Kendrick J, Kestenbaum B & Chonchol M (2011). Phosphate and cardiovascular disease. Adv Chronic Kidney Dis 18, 113-119.
37. Kestenbaum B, Glazer NL, Köttgen A, Felix JF, Hwang SJ, Liu Y, Lohman K, Kritchevsky SB, Hausman DB, Petersen AK et al. (2010). Common genetic variants associate with serum phosphorus concentration. J Am Soc Nephrol 21, 1223-1232.
38. Kido S, Kaneko I, Tatsumi S, Segawa H & Miyamoto K-I (2013). Vitamin D and type II sodium-dependent phosphate cotransporters. Contrib Nephrol 180, 86-97.
39. Knochel JP (1980). Hypophosphatemia in the alcoholic. Arch Int Med 140, 613-615.
40. Krajisnik T, Bjorkland P, Marsell R, Ljunggren O, Akerstrom G, Jonsson KB,Westin G & Larssen TE (2007). 1,25. J Endocrinol 195, 125-131.
41. Kuro-oM (2013). Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism. Nat Rev Nephrol 9, 650-660.
42. Lavi-Moshayoff V, Silver J & Naveh-Many T (2009). Human PTH gene regulation in vivo using transgenic mice. Am J Physiol Renal Physiol 297, F713-F719.
43. Lavi-Moshayoff V,Wasserman G, Meir T, Silver J & Naveh-Many T (2010). PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol 299, F882-F889.
44. Lederer E & Miyamoto K (2012). Clinical consequences of mutations in sodium phosphate cotransporters. Clin J Am Soc Nephrol 7, 1179-1187.
45. Loghman-Adham M (1997). Adaptations to changes in dietary phosphorus in health and in renal failure. J Lab ClinMed 129, 176-188.
46. McElderry J-DP, Zhao G, Khmaladze A,Wilson CG, Franceschi RT & Morris MD (2013). Tracking circadian rhythms of bone mineral deposition in murine calvarial organ cultures. J Bone Miner Res 28, 1846-1854.
47. Maiti A & Beckman MJ (2007). Extracellular calcium is a direct effector of VDR levels in proximal tubule epithelial cells that counterbalances effects of PTH on renal vitamin D metabolism. J Steroid Biochem Mol Biol 107, 504-508.
48. Marks J, Debnam ES & Unwin RJ (2010). Phosphate homeostasis and the renal-gastrointestinal axis. Am J Physiol Renal Physiol 299, F285-F296.
49. Martin A, David V & Quarles LD (2012). Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev 92, 131-155.
50. Moe SM, Zidehsarai MP, Chambers MA, Jackman LA, Radcliffe JS, Trevino LL, Donahue SE & Asplin JR (2011). Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Amer Soc Nephrol 6, 257-264.
51. Motoyama K, Inaba M, Emoto M, Morii H & Nishizawa Y (2002). Sarcoidosis initially manifesting as symptomatic hypercalcemia with the absence of organic involvement. Intern Med 41, 449-452.
52. Murray RD, Holthouser K, Clark BJ, Salyer SA, Barati MT, Khundmiri SJ & Lederer ED (2013). Parathyroid hormone (PTH) decreases type IIa sodium phosphate cotransporter (Npt2a) mRNA stability. Am J Physiol Renal Physiol 304, F1076-F1084.
53. Nissenson RA & Juppner H (2013). Parathyroid hormone. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 8th edn., ed. Rosen CJ, pp. 208-214. American Society for Bone and Mineral Research, Washington, DC, USA.
54. Nomura K, Tatsumi S, Miyagawa A, Shiozaki Y, Sasaki S, Kaneko I, ItoM, Kido S, Segawa H, SanoM, Fukuwatari T, Shibata K & Miyamoto K-I (2014). Hepatectomy-related hypophosphatemia: a novel phosphaturic factor in the liver-kidney axis. J Am Soc Nephrol DOI: 10.1681/ASN.2013060569.
55. Pavik I, Jaeger P, Ebner L,Wagner CA, Petzold K, Spichtig D, Poster D,Wuthrich RP, Russman S & Serra AL (2013). Secreted klotho and FGF23 in chronic kidney disease stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol Dial Transplant 28, 352-359.
56. Perrichot R, Garcia-Ocana A, Couette S, Comoy E, Amiel C & Friedlander G (1995). Locally formed dopamine regulates renal Na-Pi co-transport through DA1 and DA2 receptors. Biochem J 312, 433-437.
57. Portale AA, Halloran BP &Morris RC Jr (1987). Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. implications for the renal production of 1,25 dihydroxyvitamin D. J Clin Invest 80, 1147-1154.
58. Prie D & Friedlander G (2010). Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system. Clin J Am Soc Nephrol 5, 1717-1722.
59. Quinn SJ, Thomsen ARB, Pang JL, Kantham L, Brauner-Osborne H, Pollak M, Goltzman D & Brown EM (2013). Interactions between calcium and phosphorus in the regulation of the production of fibroblast growth factor 23 in vivo. Am J Physiol Endocrinol Metab 304, E310-E320.
60. Riccardi D, Traebert M,Ward DT, Kaissling B, Biber J, Hebert SC & Murer H (2000). Dietary phosphate and parathyroid hormone alter the expression of the calcium-sensing receptor (CaR) and the Na+-dependent Pi transporter (NaPi-2) in the rat proximal tubule. Pflugers Archiv 441, 379-387.
61. Rodriguez-Ortiz ME, Lopez I, Munoz-Castaneda JU, Martinez-Moreno JM, Ramirez AP, Pineda C, Canalejo A, Jaeger P, Aguilera-Tejero E, Rodriguez M, Felsenfeld A & Almaden Y (2012). Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol 23, 1190-1197.
62. Sakan H, Nakatani K, Asai O, Imura A, Tanaka T, Yoshimoto S, Iwamoto N, Kurumatani N, Iwano M, Nabeshima Y, Konishi N & Saito Y (2014). Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism. PLoS One 9, e86301.
63. Segawa H, Onitsuka A, Furutani J, Kaneko I, Aranami F, Matsumoto N, Tomoe Y, Kuwahata M, Ito M, Matsumoto M, Li M, Amizuka N & Miyamoto K (2009). Npt2a and Npt2c in mice play distinct and synergistic roles in inorganic phosphate metabolism and skeletal development. Am J Physiol Renal Physiol 297, F671-F678.
64. Sizova D, Velasquez H, Sampaio-Maia B, Quelhas-Santos J, Pestana M & Desir G (2013). Renalase regulates renal dopamine and phosphate metabolism. Am J Physiol Renal Physiol 305, F839-F844.
65. Silver J & Naveh-Many T (2012). FGF23 and the parathyroid. In Endocrine FGFs and Klothos, ed. Kuro-o M, pp. 92-99. Springer.
66. Skipper A (2012). Refeeding syndrome or refeeding hypophosphatemia: a systematic review of cases. Nutr Clin Pract 27, 34-40.
67. Streicher C, Zeitz U, Andrukhova O, Rupprecht A, Polh E, Larsson TE,WindischW, Lanske B & Erben RG (2012). Long-term FGF23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor. Endocrinology 153, 1795-1805.
68. Tiosano T & Hochberg Z (2009). Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab 27, 392-401.
69. Winkelman JW, Cannon DC, Pileggi VJ & Reed AH (1973). Estimation of norms from a controlled sample survey. II. influence of body habitus, oral contraceptives, and other factors on values for the normal range derived from the SMA 12/60 screening group of tests. Clin Chem 19, 488-491.
70. Witteveen JE, van Lierop AH, Papapoulos SE & Hamdy NAT (2012). Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism? Eur J Endocrinol 166, 55-60.
71. Xu L, Dixit MP, Chen R, Dixit NM, Collins JF & Ghishan FK (2004). Effects of angiotensin II on NaPi-IIa cotransporter expression and activity in rat renal cortex. Biochim Biophys Acta 1667, 114-121.
72. Yuan Q, Sato T, Densmore M, Saito H, Schuler C, Erben RG & Lanske B (2011). FGF23/Klotho signalling is not essential for the phosphaturic or anabolic effects of PTH. J Bone Miner Res 26, 2026-2035.
73. Zhang D, Maalouf NM, Adams-Huet B, Moe OW& Sakhaee K (2014). Effects of sex and postmenopausal estrogen use on serum phosphorus levels: a cross-sectional study of the National Health and Nutrition Examination Survey (NHANES) 2003-2006. Am J Kidney Dis 63, 198-205.